A California drug company has broken ground on its pharmaceutical manufacturing and research facility outside of Madison where it will invest up to $250 million and create 250 jobs.

Arrowhead Pharmaceuticals Inc. (Nasdaq: ARWR) of Pasadena, California, was awarded $16 million in tax incremental financing support and $2.5 million in refundable tax credit from the Wisconsin Economic Development Corp. for the project. Arrowhead is building an approximately 140,000-square-foot drug manufacturing facility and an approximately 115,000-square-foot laboratory and office facility to support process development and analytical activities.

The company purchased 13 acres in the Verona Technology Park in Verona for the facilities late last year.

Click here to read the full article.